Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16290353 | 0.93 | TSHR (0.61) | TSHRALDH1A1THRBDNM1TP53 | |
| SCHEMBL3786036 | 0.93 | TSHR (0.61) | TSHRALDH1A1THRBDNM1TP53 | |
| SCHEMBL3791084 | 0.93 | TSHR (0.61) | TSHRALDH1A1THRBDNM1TP53 | |
| SCHEMBL4580407 | 0.91 | TSHR (0.63) | TSHRALDH1A1THRBDNM1 | |
| SCHEMBL4578754 | 0.91 | TSHR (0.63) | TSHRALDH1A1THRBDNM1 | |
| SCHEMBL487323 | 0.89 | TSHR (0.62) | TSHRALDH1A1THRBDNM1CYP2C9 | |
| SCHEMBL20706516 | 0.89 | TSHR (0.62) | TSHRALDH1A1THRBDNM1CYP2C9 | |
| SCHEMBL8371105 | 0.89 | ALDH1A1 (0.62) | TSHRALDH1A1THRBDNM1HSD17B10 | |
| SCHEMBL1982870 | 0.89 | TSHR (0.61) | TSHRALDH1A1THRBDNM1 | |
| SCHEMBL1982599 | 0.89 | TSHR (0.61) | TSHRALDH1A1THRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4194523-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | Cuantum Medical Cosmetics, S.L. (ES) | 2023-06-14 | — | — | EP | claimed |
| CN-121930411-A | Gel electrolyte precursor, gel electrolyte and lithium ion battery | 宁德国泰华荣新材料有限公司 | 2026-04-28 | — | — | CN | disclosed |
| EP-4194523-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | Cuantum Medical Cosmetics, S.L. (ES) | 2023-06-14 | — | — | EP | disclosed |
| US-7341716-B2 | Occlusive composition | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-11 | — | — | US | disclosed |
| EP-1494999-B1 | OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER | BOSTON SCIENT LTD (BB) | 2006-06-07 | — | — | EP | disclosed |
| EP-1494999-A1 | OCCLUSIVE COMPOSITION COMPRISING A POLY(2-CYANOACRYLATE) MONOMER | Boston Scientific Limited (BB) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003087042-A1 | OCCLUSIVE COMPOSITION COMPRISING A POLY (2-CYANOACRYLATE) MONOMER | BOSTON SCIENTIFIC LIMITED (BB) | 2003-10-23 | — | — | WO | disclosed |
| US-20030194389-A1 | Occlusive composition | STRYKER CORPORATION | 2003-10-16 | — | — | US | disclosed |
| EP-0686681-B1 | Alpha-cyanoacrylate adhesive composition | TAOKA CHEMICAL CO LTD (JP) | 1998-08-05 | — | — | EP | disclosed |
| EP-0690112-A1 | Cyanoacrylate adhesive compositions | TAOKA CHEMICAL COMPANY, LIMITED (JP) | 1996-01-03 | — | — | EP | disclosed |
| EP-0686681-A1 | Alpha-cyanoacrylate adhesive composition | TAOKA CHEMICAL COMPANY, LIMITED (JP) | 1995-12-13 | — | — | EP | disclosed |
| EP-0063037-B1 | ADHESIVE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-25 | — | — | EP | disclosed |
| US-4377490-A | CYANOACRYLATE, ETHERS, ALCOHOLS, ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-03-22 | — | — | US | disclosed |
| EP-0063037-A2 | Adhesive composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-10-20 | — | — | EP | disclosed |
| US-4041062-A | CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS | JOHNSON & JOHNSON (US) | 1977-08-09 | — | — | US | disclosed |
| US-4041063-A | CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS | JOHNSON & JOHNSON (US) | 1977-08-09 | — | — | US | disclosed |
| US-4041061-A | CROSSLINKING AGENTS FOR DENTAL ADHESIVE, SEALING OR COATING POLYMERS | JOHNSON & JOHNSON (US) | 1977-08-09 | — | — | US | disclosed |
| US-4013703-A | CROSSLINKING AGENTS; MONOMERS FOR ADHESIVE POLYMERS | JOHNSON & JOHNSON (US) | 1977-03-22 | — | — | US | disclosed |
| US-4003942-A | CROSSLINKING AGENTS; DENTAL ADHESIVES | JOHNSON & JOHNSON (US) | 1977-01-18 | — | — | US | disclosed |
| US-3975422-A | Preparation of bis (2-cyanoacrylate)monomers | JOHNSON & JOHNSON (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194389-A1 | Occlusive composition | C3AR1, F12, FGB | TSHR 3434/4885ALDH1A1 1135/4885THRB 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.